Browser-side verification
Verify Atenolol
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "atenolol",
"nameEn": "Atenolol",
"nameTh": "อะทีโนลอล",
"class": "Beta blocker — cardioselective β1 antagonist",
"mechanism": "ยาปิดกั้น β1-adrenergic receptor แบบ cardioselective ลดอัตราการเต้นและแรงบีบหัวใจ ลด oxygen demand และคุม arrhythmia; ใช้บ่อยในแมวที่มี HCM",
"brandNamesTh": [
"Tenormin"
],
"indications": [
{
"text": "คุม supraventricular/ventricular arrhythmia ระดับไม่รุนแรง, hypertrophic cardiomyopathy (โดยเฉพาะในแมว), และ systemic hypertension เป็นยาเสริม",
"cites": [
"merck-antiarrhythmics",
"tufts-cardiorush"
]
}
],
"contraindications": [
{
"text": "ห้าม/ระวังมากใน CHF ที่ยังไม่คงที่ (กดการบีบหัวใจ), bradyarrhythmia, AV block, asthma/bronchospasm; ห้ามหยุดยากะทันหัน (rebound tachycardia)",
"cites": [
"tufts-cardiorush"
]
}
],
"sideEffects": [
{
"text": "หัวใจเต้นช้า, ความดันต่ำ, ซึม, ทำให้ CHF แย่ลงหากใช้ผิดจังหวะ; ปรับลดในไตบกพร่อง (ขับทางไต)",
"cites": [
"tufts-cardiorush"
]
}
],
"dosages": [
{
"species": "canine",
"indication": "Arrhythmia / hypertension",
"route": "PO",
"dose": "0.25–1 mg/kg PO ทุก 12–24 ชั่วโมง",
"cites": [
"tufts-cardiorush",
"merck-antiarrhythmics"
]
},
{
"species": "feline",
"indication": "HCM / arrhythmia",
"route": "PO",
"dose": "6.25–12.5 mg/ตัว PO ทุก 12 ชั่วโมง",
"cites": [
"tufts-cardiorush"
]
}
],
"citations": [
{
"id": "merck-antiarrhythmics",
"type": "textbook",
"title": "Antiarrhythmics for Use in Animals — MSD/Merck Veterinary Manual",
"year": 2025,
"url": "https://www.msdvetmanual.com/pharmacology/systemic-pharmacotherapeutics-of-the-cardiovascular-system/antiarrhythmics-for-use-in-animals",
"note": "Merck — beta-blocker, sotalol, Ca-channel-blocker dosing. Copyrighted, cited not mirrored.",
"cid": null
},
{
"id": "tufts-cardiorush",
"type": "guideline",
"title": "Cardiology Drug Formulary — Tufts CardioRush",
"year": 2024,
"url": "https://sites.tufts.edu/cardiorush/cardiology-drug-formulary/",
"note": "Tufts Cummings veterinary cardiology academic formulary. Authoritative reference for cardiac dosing.",
"cid": null
},
{
"id": "dailymed-atenolol",
"type": "regulatory-database",
"title": "Atenolol — NLM DailyMed (FDA Structured Product Labeling)",
"year": 2025,
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=atenolol",
"note": "Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.",
"cid": "3c08a0ab368eaf6071c0f6c3d727e43b26f5cb3008825ff2f1afeede4e96e123"
},
{
"id": "atc-C07AB03",
"type": "guideline",
"title": "ATC C07AB03 — Atenolol",
"year": 2025,
"url": "https://www.whocc.no/atc_ddd_index/?code=C07AB03&showdescription=no",
"note": "Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.",
"cid": "fc16b8cafa5f8ec348c3113599ec866962503692ebd6f6cf968dc5c50609092b"
},
{
"id": "pubchem-atenolol",
"type": "monograph",
"title": "Atenolol — PubChem search",
"year": 2025,
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Atenolol",
"note": "Cross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.",
"cid": "b9cc6ea5ac326d68a67183f82388f8a3906f406f2d576b38a4757bb78bee52ab"
},
{
"id": "who-eml-22",
"type": "guideline",
"title": "WHO Model List of Essential Medicines (22nd List, 2021)",
"year": 2021,
"url": "https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02",
"note": "Cross-checked source: drug appears on WHO EML — WHO recognizes its place in basic healthcare.",
"cid": "71030c795c4e0c0cff56566bfc9ae4ed448eab9188ae68ce773a50d9f7fc53eb"
}
],
"mirroredFrom": [
{
"id": "dailymed",
"name": "NLM DailyMed",
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=atenolol",
"asOfDate": "2026-05-27",
"license": "U.S. Government work — public domain. Attribution recommended."
},
{
"id": "atc",
"name": "WHO ATC Classification",
"url": "https://www.whocc.no/atc_ddd_index/?code=C07AB03&showdescription=no",
"asOfDate": "2026-05-27",
"license": "WHO publication, free for use with attribution"
},
{
"id": "pubchem",
"name": "PubChem (NIH/NLM)",
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Atenolol",
"asOfDate": "2026-05-27",
"license": "NIH/NLM public domain"
},
{
"id": "who-eml",
"name": "WHO Model List of Essential Medicines (22nd List, 2021)",
"url": "https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02",
"asOfDate": "2026-05-27",
"license": "CC BY-NC-SA 3.0 IGO"
}
],
"mirrorCIDs": [
{
"sourceId": "dailymed",
"cid": "3c08a0ab368eaf6071c0f6c3d727e43b26f5cb3008825ff2f1afeede4e96e123",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "atc",
"cid": "fc16b8cafa5f8ec348c3113599ec866962503692ebd6f6cf968dc5c50609092b",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "pubchem",
"cid": "b9cc6ea5ac326d68a67183f82388f8a3906f406f2d576b38a4757bb78bee52ab",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "who-eml",
"cid": "71030c795c4e0c0cff56566bfc9ae4ed448eab9188ae68ce773a50d9f7fc53eb",
"capturedAt": "2026-05-27",
"status": "stub"
}
],
"codes": {
"atc": {
"code": "C07AB03",
"name": "Atenolol",
"level": 5
},
"rxnorm": {
"cui": "1202",
"name": "Atenolol"
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-05-27",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-05-27",
"version": 1,
"changelog": [
{
"version": 0,
"date": "2026-05-27",
"summary": "Seed entry — cross-checked from 4 authoritative sources (NLM DailyMed, WHO ATC Classification, PubChem (NIH/NLM), WHO Model List of Essential Medicines (22nd List, 2021)). ATC C07AB03 + RxNorm 1202. Thai translation + faculty review pending."
},
{
"version": 1,
"date": "2026-05-27",
"summary": "Clinical content compiled from cited sources — atenolol dog 0.25–1 mg/kg, cat 6.25–12.5 mg/cat q12h verified against Tufts CardioRush + Merck antiarrhythmics. Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
]
}Public keys used
[]